Vericel (VCEL) Stock: Gaining Ahead Of Key Presentation

Vericel Corp (NASDAQ: VCEL) is having an overwhelmingly strong day in the market today following an announcement that the company would be giving a presentation soon. Before we get into the details here, we’d like to thank our partners at Trade Ideas for being the first to alert us to the gains. At the moment (12:05), VCEL is trading at $5.35 per share after a gain of $0.45 per share or 9.18% thus far today.

VCEL To Present Soon

As mentioned above, Vericel is having an overwhelmingly strong day in the market today after the company released an early morning announcement informing investors of an upcoming presentation. The company, focused on developing expanded autologous cell therapies for the treatment of serious diseases and conditions, announced that it would be presenting at the Cell & Gene Meeting. The meeting will be held on the Mesa at the Estancia La Jolla Hotel & Spa in La Jolla, CA on Wednesday October 4th, 2017 at 5:45pm Pacific Time.

During the presentation, Nick Colangelo, President and CEO at VCEL will be offering insight on what approval means in his plenary session “Implications of Commercialization: What Does Approval Mean?”

The Cell & Gene Meeting on the Mesa is a 3-day event featuring three distinct parts. The event is organized by the Alliance for Regenerative Medicine, also known as ARM as well as the Sanford Stem Cell Clinic Center at UC San Diego.

If you are unable to attend to conference, but would like to see the presentation, you can do so by viewing the live webcast offered here.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on VCEL. In particular, we’re interested in following the presentation to learn more about the company’s push toward approval and commercialization. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

Leave a Comment